Durvalumab in HIV-1 Patients With Solid Tumors
Clinical trial NCT03094286 · COMPLETED
Trial details
- NCT number
- NCT03094286
- Sponsor
- Spanish Lung Cancer Group
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-04-24
- Primary completion
- 2019-04-24
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.